Skip to main content
. 2021 Jan 7;23(3):672–679. doi: 10.1111/jch.14168

TABLE 1.

Demographic data

Group p

Intervention

n = 55

Control

n = 55

Age, years 66.76 (12.64) 60.76 (12.64) .013
Female, n (%) 35 (63.64) 34 (61.82) .844
Marital Status, n (%)
Married 34 (61.82) 30 (54.55) .789
Single 11 (20.00) 14 (25.45)
Widowed 7 (12.73) 9 (19.36)
Separated/Divorced 3 (5.45) 2 (3.64)
Education, n (%)
Primary school 6 (10.91) 13 (23.64) .339
High school 15 (27.27) 11 (20.00)
Bachelor's Degree or Higher 34 (61.82) 31 (56.38)
Occupation, n (%)
Housekeeper 3 (5.45) 9 (16.36) .124
Farmer 27 (49.09) 18 (32.73)
Government officer 14 (25.45) 19 (34.55)
Personal business owner 11 (20.00) 9 (16.36)
History of smoking, n (%)
Never smoked 31 (56.36) 32 (58.18) .767
Former smoker 17 (30.91) 15 (27.27)
Actively smoking 0 (0.00) 8 (14.55)
History of alcohol, n (%)
Never drank alcohol 36 (65.45) 36 (65.45) .590
Former alcohol drinker 13 (23.64) 14 (25.45)
Actively drinks alcohol 6 (10.91) 5 (9.09)
Underlying disease, n (%)
Hypertension 30 (54.55) 28 (50.91) .849
Diabetes mellitus 5 (9.09) 5 (9.09) 1.000
Dyslipidemia 4 (7.27) 4 (7.27) 1.000
Atrial fibrillation 2 (3.64) 2 (3.64) 1.000
Others 14 (25.45) 9 (16.36) .248
The duration of hypertension diagnosis, years 2.44 (1.27) 2.56 (1.20) .590
Creatinine, mg/dl (mean ± SD) 0.92 ± 0.37 0.98 ± 0.37 .423
eGFR, ml/min/1.73m2 (mean ± SD) 61.90 ± 26.48 60.67 ± 25.88 .806
Chief complaints of current visit, n (%)
Asymptomatic 36 (65.45) 35 (63.64) .642
Dizziness 7 (12.73) 5 (9.09)
Headache 4 (7.27) 8 (14.55)
Blurred vision 4 (7.27) 4 (7.27)
Shortness of breath 4 (7.27) 3 (5.46)
Antihypertensive medication use, n (%)
Untreated 15 (27.27) 17 (30.91) .195
Stopped independently 10 (18.18) 3 (5.45) .041
Irregularly taken 17 (30.91) 17 (30.91) 1.000
Regularly taken, n (%) 13 (23.64) 18 (32.73) .295
Calcium channel blockers 12 (21.82) 18 (32.73) .284
ACEI 3 (5.45) 3 (5.45) 1.000
ARB 5 (9.09) 6 (10.91) 1.000
Hydralazine 9 (16.36) 12 (21.82) .628
Prescribed antihypertensive medication in ER, n (%) 51 (92.73) 52 (94.55) .068
Amlodipine 19 (34.55) 34 (61.82) .007
Captopril 0 (0) 4 (7.27) .118
Hydralazine 49 (89.09) 51 (92.73) .742

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitors; ARB, angiotensin II receptor blockers; eGFR, estimated glomerular filtration rate; ER, emergency room.